CRISPR-edited immune cells can survive and thrive after infusion into cancer patients

by Perelman School of Medicine at the University of PennsylvaniaGraphic showing genetic alternations of cells tested in trial. Credit: Joseph Fraietta, PhD, University of PennsylvaniaGenetically-

Updated on: April 12,2024

CRISPR-edited immune cells can survive and thrive after infusion into cancer patients

by Perelman School of Medicine at the University of PennsylvaniaGraphic showing genetic alternations of cells tested in trial. Credit: Joseph Fraietta, PhD, University of PennsylvaniaGenetically-

Updated on:April 12,2024

New drug combination shows promise for common pediatric brain tumor

by Larry Frum,Johns Hopkins University School of MedicineThe introduction of everolimus with carboplatin treatment induces DNA damage in tumor cells and kills them. Credit: Johns Hopkins Kimmel

Updated on: March 06,2024

New drug combination shows promise for common pediatric brain tumor

by Larry Frum,Johns Hopkins University School of MedicineThe introduction of everolimus with carboplatin treatment induces DNA damage in tumor cells and kills them. Credit: Johns Hopkins Kimmel

Updated on:March 06,2024

Scientists create cost-effective, easy-to-use test to categorize a child's cancer and guide better treatment

bySt. Jude Children's Research Hospital(L to R) Co-corresponding author Jeff Klco, MD, PhD, St. Jude Department of Pathology, co-corresponding author Xiaotu Ma, PhD, St. Jude Department of C

Updated on: August 28,2024

Scientists create cost-effective, easy-to-use test to categorize a child's cancer and guide better treatment

bySt. Jude Children's Research Hospital(L to R) Co-corresponding author Jeff Klco, MD, PhD, St. Jude Department of Pathology, co-corresponding author Xiaotu Ma, PhD, St. Jude Department of C

Updated on:August 28,2024

Clinical trial: Some sarcoma patients improve with T cell immunotherapy

by Julia Evangelou Strait,Washington University School of Medicine in St. LouisCredit: Pixabay from PexelsA clinical trial led by researchers at Washington University School of Medicine in St. L

Updated on: March 30,2024

Clinical trial: Some sarcoma patients improve with T cell immunotherapy

by Julia Evangelou Strait,Washington University School of Medicine in St. LouisCredit: Pixabay from PexelsA clinical trial led by researchers at Washington University School of Medicine in St. L

Updated on:March 30,2024

AI's ability to detect tumor cells could be key to more accurate bone cancer prognoses

byKyushu UniversityResearchers from Kyushu University, Japan have developed a novel deep-learning model which can accurately estimate viable tumor cell density from pathological images of osteos

Updated on: April 30,2024

AI's ability to detect tumor cells could be key to more accurate bone cancer prognoses

byKyushu UniversityResearchers from Kyushu University, Japan have developed a novel deep-learning model which can accurately estimate viable tumor cell density from pathological images of osteos

Updated on:April 30,2024

Finding molecular secrets hidden in premature aging diseases and cancer using AI

byInsilico MedicineSchematic representation of the PandaOmics application for a rapid biomarker discovery and target characterization in cancer. Gene expression signatures have been examined in

Updated on: December 28,2023

Finding molecular secrets hidden in premature aging diseases and cancer using AI

byInsilico MedicineSchematic representation of the PandaOmics application for a rapid biomarker discovery and target characterization in cancer. Gene expression signatures have been examined in

Updated on:December 28,2023

Combined MET and PD-L1 inhibition shows promise in MET-driven metastatic papillary renal cancer

by Vall d'Hebron Institute of OncologyCredit: Pixabay/CC0 Public DomainAdvanced papillary renal cancer (PRC) has a poor prognosis with few treatment options available. Approximately 30% of patient

Updated on: December 28,2023

Combined MET and PD-L1 inhibition shows promise in MET-driven metastatic papillary renal cancer

by Vall d'Hebron Institute of OncologyCredit: Pixabay/CC0 Public DomainAdvanced papillary renal cancer (PRC) has a poor prognosis with few treatment options available. Approximately 30% of patient

Updated on:December 28,2023

'Bone in a dish' opens new window on cancer initiation, metastasis, bone healing

by Oregon Health & Science UniversityLuiz Bertassoni D.D.S., Ph.D., and Avathamsa Athirasala, M.Sc.Eng., inspect the 3D mineral structure populated with living cells, providing a unique model

Updated on: March 13,2024

'Bone in a dish' opens new window on cancer initiation, metastasis, bone healing

by Oregon Health & Science UniversityLuiz Bertassoni D.D.S., Ph.D., and Avathamsa Athirasala, M.Sc.Eng., inspect the 3D mineral structure populated with living cells, providing a unique model

Updated on:March 13,2024

Each year spent working with certain chemicals raises risk of pancreatic cancer, finds study

by Dennis ThompsonJobs that regularly expose you to certain chemicals appear to steadily increase your risk of pancreatic cancer, a new analysis reports.People with more than 20 years of exposure to s

Updated on: January 23,2024

Each year spent working with certain chemicals raises risk of pancreatic cancer, finds study

by Dennis ThompsonJobs that regularly expose you to certain chemicals appear to steadily increase your risk of pancreatic cancer, a new analysis reports.People with more than 20 years of exposure to s

Updated on:January 23,2024

ACA has provided better access to care for cancer survivors

(HealthDay)—Cancer survivors are more likely to have difficulty accessing and affording health care, but the proportion reporting these issues is decreasing, according to a study published online Marc

Updated on: March 27,2024

ACA has provided better access to care for cancer survivors

(HealthDay)—Cancer survivors are more likely to have difficulty accessing and affording health care, but the proportion reporting these issues is decreasing, according to a study published online Marc

Updated on:March 27,2024

Researchers analyze factors contributing to high levels of esophageal cancer in Tanzania

byThe City University of New YorkAssociations between the number of hospitals and esophageal cancer incidence with or without Dar es Salam hospital. Credit:Journal of Cancer Epidemiology&n

Updated on: January 29,2024

Researchers analyze factors contributing to high levels of esophageal cancer in Tanzania

byThe City University of New YorkAssociations between the number of hospitals and esophageal cancer incidence with or without Dar es Salam hospital. Credit:Journal of Cancer Epidemiology&n

Updated on:January 29,2024

Even when at low risk, some women should remove fallopian tubes to avoid ovarian cancer, say experts

by Cara MurezMore women, even those at low risk for ovarian cancer, who have finished having children should have their fallopian tubes removed as a precaution to prevent the deadly disease, a leading

Updated on: January 21,2024

Even when at low risk, some women should remove fallopian tubes to avoid ovarian cancer, say experts

by Cara MurezMore women, even those at low risk for ovarian cancer, who have finished having children should have their fallopian tubes removed as a precaution to prevent the deadly disease, a leading

Updated on:January 21,2024